Common Stock
- Symbol
- RVP
- Exchange
- NYSEAMER
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Retractable Technologies, Inc
RVPNYSE_AMERICANEQUITYCurrent
Other Events
Item 8.01 Other Events. On September 30, 2026, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.
Press release in this filing
RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B →Company context
Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.
Current securities
Registered securities in this filing
Retractable Technologies, Inc. · 8-K · Filed 2026-09-30
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On September 30, 2026,
the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing the declaration of
a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.